Glabat Solid‐State Battery Inc. (GLABAT), Canada

Time frame: 1 December 2022 - 30 November 2023

Profile

The positions in the table below reflect the Glabat Solid‐State Battery Inc. (GLABAT)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Glabat Solid‐State Battery Inc. (GLABAT) is listed.

Position by research output Share

Global Canada
Overall 4789 129
Corporate 677 25

Position by research output Share in subject areas

Global Canada
Chemistry 2218 68
Physical sciences 2268 61

Research

Overall research output

Count Share
Overall 3 0.28

Overall Count and Share for 'Glabat Solid‐State Battery Inc. (GLABAT)' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Chemistry 2 0.16
Physical sciences 2 0.22

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.

Collaboration

International vs domestic collaboration by Share

Type Percentage
International (6 institutions) 47.8%
Domestic (3 institutions) 52.2%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Glabat Solid‐State Battery Inc. (GLABAT) by Share

Collaborating institutions

Share

Top 5 international collaborators with Glabat Solid‐State Battery Inc. (GLABAT) by Share

Collaborating institutions

Share

  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences